Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.

CD317/tetherin (aka BST2 or HM1.24 antigen) is an interferon inducible membrane protein present in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts). It has been implicated in an eclectic mix of cellular processes including, most notably, the retention...

Full description

Bibliographic Details
Main Authors: Ruth Rollason, Katie Dunstan, Peter G Billcliff, Paul Bishop, Paul Gleeson, Helen Wise, Paul Digard, George Banting
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3782430?pdf=render
id doaj-1d61ca2e839a4f198d470ebb3c46b1a8
record_format Article
spelling doaj-1d61ca2e839a4f198d470ebb3c46b1a82020-11-25T01:21:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7568010.1371/journal.pone.0075680Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.Ruth RollasonKatie DunstanPeter G BillcliffPaul BishopPaul GleesonHelen WisePaul DigardGeorge BantingCD317/tetherin (aka BST2 or HM1.24 antigen) is an interferon inducible membrane protein present in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts). It has been implicated in an eclectic mix of cellular processes including, most notably, the retention of fully formed viral particles at the surface of cells infected with HIV and other enveloped viruses. Expression of the HIV viral accessory protein Vpu has been shown to lead to intracellular sequestration and degradation of tetherin, thereby counteracting the inhibition of viral release. There is evidence that tetherin interacts directly with Vpu, but it remains unclear where in the cell this interaction occurs or if Vpu expression affects the lipid raft localisation of tetherin. We have addressed these points using biochemical and cell imaging approaches focused on endogenous rather than ectopically over-expressed tetherin. We find i) no evidence for an interaction between Vpu and endogenous tetherin at the cell surface, ii) the vast majority of endogenous tetherin that is at the cell surface in control cells is in lipid rafts, iii) internalised tetherin is present in non-raft fractions, iv) expression of Vpu in cells expressing endogenous tetherin leads to the loss of tetherin from lipid rafts, v) internalised tetherin enters early endosomes, and late endosomes, in both control cells and cells expressing Vpu, but the proportion of tetherin molecules destined for degradation rather than recycling is increased in cells expressing Vpu vi) lysosomes are the primary site for degradation of endogenous tetherin in cells expressing Vpu. Our studies underlie the importance of studying endogenous tetherin and let us propose a model in which Vpu intercepts newly internalised tetherin and diverts it for lysosomal destruction rather than recycling to the cell surface.http://europepmc.org/articles/PMC3782430?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ruth Rollason
Katie Dunstan
Peter G Billcliff
Paul Bishop
Paul Gleeson
Helen Wise
Paul Digard
George Banting
spellingShingle Ruth Rollason
Katie Dunstan
Peter G Billcliff
Paul Bishop
Paul Gleeson
Helen Wise
Paul Digard
George Banting
Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
PLoS ONE
author_facet Ruth Rollason
Katie Dunstan
Peter G Billcliff
Paul Bishop
Paul Gleeson
Helen Wise
Paul Digard
George Banting
author_sort Ruth Rollason
title Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
title_short Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
title_full Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
title_fullStr Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
title_full_unstemmed Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
title_sort expression of hiv-1 vpu leads to loss of the viral restriction factor cd317/tetherin from lipid rafts and its enhanced lysosomal degradation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description CD317/tetherin (aka BST2 or HM1.24 antigen) is an interferon inducible membrane protein present in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts). It has been implicated in an eclectic mix of cellular processes including, most notably, the retention of fully formed viral particles at the surface of cells infected with HIV and other enveloped viruses. Expression of the HIV viral accessory protein Vpu has been shown to lead to intracellular sequestration and degradation of tetherin, thereby counteracting the inhibition of viral release. There is evidence that tetherin interacts directly with Vpu, but it remains unclear where in the cell this interaction occurs or if Vpu expression affects the lipid raft localisation of tetherin. We have addressed these points using biochemical and cell imaging approaches focused on endogenous rather than ectopically over-expressed tetherin. We find i) no evidence for an interaction between Vpu and endogenous tetherin at the cell surface, ii) the vast majority of endogenous tetherin that is at the cell surface in control cells is in lipid rafts, iii) internalised tetherin is present in non-raft fractions, iv) expression of Vpu in cells expressing endogenous tetherin leads to the loss of tetherin from lipid rafts, v) internalised tetherin enters early endosomes, and late endosomes, in both control cells and cells expressing Vpu, but the proportion of tetherin molecules destined for degradation rather than recycling is increased in cells expressing Vpu vi) lysosomes are the primary site for degradation of endogenous tetherin in cells expressing Vpu. Our studies underlie the importance of studying endogenous tetherin and let us propose a model in which Vpu intercepts newly internalised tetherin and diverts it for lysosomal destruction rather than recycling to the cell surface.
url http://europepmc.org/articles/PMC3782430?pdf=render
work_keys_str_mv AT ruthrollason expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT katiedunstan expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT petergbillcliff expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT paulbishop expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT paulgleeson expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT helenwise expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT pauldigard expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
AT georgebanting expressionofhiv1vpuleadstolossoftheviralrestrictionfactorcd317tetherinfromlipidraftsanditsenhancedlysosomaldegradation
_version_ 1725129844541358080